| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-14-1087 |
| P698 | PubMed publication ID | 25278450 |
| P50 | author | Markus Ringnér | Q37374913 |
| Hans Brunnström | Q56250364 | ||
| P2093 | author name string | Anna Karlsson | |
| Göran Jönsson | |||
| Johan Staaf | |||
| Åke Borg | |||
| Maria Planck | |||
| Mats Jönsson | |||
| Per Jönsson | |||
| Martin Lauss | |||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| adenocarcinoma | Q356033 | ||
| DNA methylation | Q874745 | ||
| lung carcinoma | Q18556110 | ||
| P304 | page(s) | 6127-6140 | |
| P577 | publication date | 2014-10-02 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome | |
| P478 | volume | 20 |
| Q64121645 | A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer |
| Q52587816 | A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer. |
| Q98170163 | A new clinical prognostic nomogram for liver cancer based on immune score |
| Q92683573 | A novel CpG island methylation panel predicts survival in lung adenocarcinomas |
| Q92029585 | Absence of an embryonic stem cell DNA methylation signature in human cancer |
| Q36628822 | An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells. |
| Q33813245 | Combination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells |
| Q92937338 | Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis |
| Q40630283 | Comparison and combination of blood DNA methylation at smoking-associated genes and at lung cancer-related genes in prediction of lung cancer mortality |
| Q37619692 | Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma |
| Q66475599 | DNA methylation of LRRC3B: a biomarker for survival of early-stage non-small cell lung cancer patients. |
| Q57469406 | EWASdb: epigenome-wide association study database |
| Q28087759 | Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer |
| Q55398948 | Epigenetic modifications in KDM lysine demethylases associate with survival of early-stage NSCLC. |
| Q38779229 | Establishment and Characterization of a Human Neuroendocrine Tumor Xenograft |
| Q51418643 | Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors. |
| Q92593617 | Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment |
| Q41101024 | Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis |
| Q89955829 | Independent validation of early-stage NSCLC prognostic scores incorporating epigenetic and transcriptional biomarkers with gene-gene interactions and main effects |
| Q89967411 | Integrative Analysis of Methylation and Gene Expression in Lung Adenocarcinoma and Squamous Cell Lung Carcinoma |
| Q90639806 | Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells |
| Q36355858 | Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer |
| Q38841735 | NETs: organ-related epigenetic derangements and potential clinical applications |
| Q37701692 | Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer |
| Q36862682 | Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer. |
| Q38768455 | Role of ATG10 expression quantitative trait loci in non-small cell lung cancer survival |
| Q64105996 | SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic-smoking interaction analysis |
| Q47100621 | Significant associations between driver gene mutations and DNA methylation alterations across many cancer types. |
| Q90239888 | The Role of HOX Transcription Factors in Cancer Predisposition and Progression |
| Q37190352 | The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer |
| Q52725383 | The tobacco carcinogen NNK drives accumulation of DNMT1 at the GR promoter thereby reducing GR expression in untransformed lung fibroblasts. |
| Q92756583 | Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma |
| Q37219171 | Uncovering Driver DNA Methylation Events in Nonsmoking Early Stage Lung Adenocarcinoma |
| Q38769421 | Unravelling the biology of SCLC: implications for therapy |
Search more.